The Effect of Bisphosphonate Treatment on Blood Lipid Parameters in Patients with Postmenopausal Osteoporosis
Bisphosphonates are currently the most preferred class of drugs used for the treatment of metabolic bone disease such as osteoporosis and Paget’s disease. Although their exact mechanism has not been identified, the compounds containing amino group (amino bisphosphonates) were shown to decrease osteo...
Saved in:
| Main Authors: | Canan Tıkız, Fatma Taneli, Çiğdem Tüzün |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2005-03-01
|
| Series: | Türk Osteoporoz Dergisi |
| Subjects: | |
| Online Access: | http://www.turkosteoporozdergisi.org/article_4225/The-Effect-Of-Bisphosphonate-Treatment-On-Blood-Lipid-Parameters-Inpatients-With-Postmenopausal-Osteoporosis |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01) -
Blood lipid profiles associated with metastatic sites in advanced gastric cancer
by: Hui Zhang, et al.
Published: (2024-11-01) -
Associations of Serum Lipid Traits With Fracture and Osteoporosis: A Prospective Cohort Study From the UK Biobank
by: Xi Xiong, et al.
Published: (2024-12-01) -
PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01) -
Predictors of plasma HDL-C concentrations in the Coronary Artery Risk Development in Young Adults (CARDIA) study
by: James M. Shikany, et al.
Published: (2025-01-01)